As optimally matured DCs prime antigen-specific CD4+ and CD8+ T cell activation and proliferation of naive T cells [7], we next assessed whether proTα- and proTα(100–109)-matured DCs are functionally competent, i.e., induce in vitro the selective expansion of tumor antigen-specific T cells. This evidence concerns the gene CD4 and neoplasm.